Lane Lawyers Plan To Challenge FDA Restitution Power Under FD&C Act
This article was originally published in The Tan Sheet
Lane Labs-USA plans to appeal a permanent injunction on sales of supplements marketed as cancer therapies handed down by a New Jersey federal court, according to Lane attorney Mark Ullman of New York-based Ullman, Shapiro and Ullman
You may also be interested in...
Industry should continue to press for coverage of supplements under health savings and flexible spending accounts, Rep. Chris Cannon (R-Utah) said at the National Nutritional Food Association's Natural Products Convention in Las Vegas July 18
The seven-year struggle between FDA and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 9
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC